Company News 

Casper’s IPO: the end of unicorn fever?

Casper’s IPO: the end of unicorn fever?

As one of the first major IPOs of the year, Casper’s (CSPR) debut proved a bruising experience. The bed-in-a-box company gained unicorn status last year after a round of private funding valued it at $1.1bn (£0.85bn). But it exited the club before even reaching the public market with the mid-point of its initial $17-£19 IPO price implying a market capitalisation of $705m. Reducing its listing price to $12-$13, this pushed its valuation down to just $495m.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now